Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia.Guillermo Ortí,Valentín García-Gutiérrez,Guiomar Bautista,Francisca Ferrer-Marín,Rolando Vallansot,Blanca Xicoy, Àngela Sánchez, Isabel Simon,Ana Triguero,Magdalena Sierra,Luis Felipe CasadoLeukemia research(2022)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要